Skip to main content

Table 2 Data from 46 salvage lymph node dissections from 43 patients with nodal prostate cancer relapse

From: Toxicity and quality of life after choline-PET/CT directed salvage lymph node dissection and adjuvant radiotherapy in nodal recurrent prostate cancer

Variables Value
Age at salvage lymph node dissection (years)  
 Mean/SD/median/range 64.9/5.9/65.2/75 - 53
Time from primary therapy to salvage lymph node dissection (years)  
 Mean/SD/median/range 4.9/3.4/4.4/15.7 – 0.4
Regions affected with lymph node metastases (Histopathology) n (%)  
 Pelvic only 31/46 (67%)
 Retroperitoneal only 5/46 (11%)
 Pelvic and retroperitoneal 9/46 (20%)
 Retroclavicular and retroperitoneal 1/46 (2%)
Number of lymph nodes removed per surgery  
 Mean/SD/median/range 29.3/14.6/29.5/2 - 62
Number of removed lymph nodes metastases per surgery  
 Mean/SD/median/range 7.9/4.5/8.6/1 - 44
PSA at salvage lymph node dissection (ng/ml)  
 Mean/SD/median/range 8.7/14.5/3.2/0.57 – 72.62